Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Trazodone for Painful Diabetic Neuropathy
NCT03202979Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- May 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of trazodone hydrochloride prolonged-release tablets in diabetic neuropathy, sponsored by Angelini Pharma. Started May 2017; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT03202979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202979.